Fludarabine is effective in the treatment of splenic lymphoma with villous lymphocytes
- PMID: 9359516
- DOI: 10.1046/j.1365-2141.1997.3523168.x
Fludarabine is effective in the treatment of splenic lymphoma with villous lymphocytes
Abstract
We report on the use of fludarabine in four patients with splenic lymphoma with villous lymphocytes (SLVL). All four had relapsed after, or failed to respond to, recommended first-line therapies. In each case fludarabine resulted in a complete clinico-haematological response with minimal toxicity, which, in the two patients with long-term follow-up, proved durable. Fludarabine is effective in the treatment of SLVL and should be considered as both a first-line therapeutic option as well as salvage therapy in this condition.
Comment in
-
Splenic lymphoma with villous lymphocytes (SLVL) responding to 2-chlorodeoxyadenosine (2-CdA).Br J Haematol. 1998 Mar;100(3):609. doi: 10.1046/j.1365-2141.1998.0636f.x. Br J Haematol. 1998. PMID: 9504654 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
